Ceritinib
CAS 1032900-25-6
In Stock
Ceritinib
Cat. No. ANT-CRT-000CAS 1032900-25-6In Stock
Technical Data
Cat. No.ANT-CRT-000
CAS1032900-25-6
Mol. FormulaC28H36ClN5O3S
Mol. Weight558.14 g/mol
IUPAC5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine
SMILESCC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl
InChIInChI=1S/C28H36ClN5O3S/c1-17(2)37-25-15-21(20-10-12-30-13-11-20)19(5)14-24(25)33-28-31-16-22(29)27(34-28)32-23-8-6-7-9-26(23)38(35,36)18(3)4/h6-9,14-18,20,30H,10-13H2,1-5H3,(H2,31,32,33,34)
InChI KeyVERWOWGGCGHDQE-UHFFFAOYSA-N
Purity99%
Description
Overview
Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene.Ceritinib is an antineoplastic (cancer) agent
Anant Labs manufacture and furnish high quality Ceritinib impurities for global markets. Our Ceritinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamineceritinib1032900-25-6LDK378ZYKADIALDK-378NVP-LDK378-NXLDK 378ceritinibumK418KG2GET